Welcome to the e-CCO Library!

P567: Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activity
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hlavaty T., Krajcovicova A., Kollerova J., Koller T., Leskova Z., Sturdik I., Payer J.

Created: Wednesday, 20 February 2019, 10:36 AM
P567: How can we predict the development of antibodies to infliximab in Crohn's disease?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ferreira, A.I.(1)*;Lima Capela, T.(1);Macedo Silva, V.(1);Xavier, S.(1);Arieira, C.(1);Cúrdia Gonçalves, T.(1);Dias de Castro, F.(1);Moreira, M.J.(1);Cotter, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P567: Long-term outcome of perianal fistulae treated with anti-TNFα therapy in a cohort of Saudi patients with Crohn’s disease based on Parks classification
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Azzam1*, O. Alharbi1, A. Aljebreen1, A. Mohammed1, S. Bahammam1, A. Bashmail1, Y. Alomar1, M. Mosli2, M. Almadi1

Created: Thursday, 21 February 2019, 9:14 AM
P567: Pharmacist-managed immunomodulator clinic in titration and monitoring of immunosuppressants in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ng, V.(1);Lim, T.G.(1,2);Ong, W.C.(1);Wong, S.Y.A.(1);Salazar, E.(3);Chan, P.W.W.(2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P567: Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
Year: 2022
Source: ECCO'22
Authors: Honap, S.(1,2);Sharma, E.(1);Ray, S.(1);Mawdsley, J.(1);Anderson, S.(1);Samaan, M.(1);Pavlidis, P.(1,2);Irving, P.(1);
Created: Friday, 11 February 2022, 3:56 PM
P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

W. Reinisch1, X. Hébuterne2, A. Buisson3, S. Schreiber4, P. Desreumaux5, J.M. Paillarse6, C. Bonny7

Created: Thursday, 30 January 2020, 10:12 AM
P568: Bowel ultrasonography is useful to evaluate disease activity in ulcerative colitis patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Takahashi*1, Y. Hirano1, K. Izumikawa1, H. Colvin1, M. Colvin1, T. Kagawa1, Y. Aoyama1, M. Matsueda1, Y. Kawai1, K. Okamoto1, I. Sakakihara1, K. Yamamoto1, S. Tanaka1, M. Matsuura1, S. Ishikawa1, M. Wato1, T. Hasui1, T. Inaba1

Created: Friday, 22 February 2019, 9:41 AM
P568: Does infliximab therapy increase incidence of tuberculosis in patients with inflammatory bowel disease in an endemic area: a nationwide study from China
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ye L., Liu J., Lin Z., Cao Q.

Created: Wednesday, 20 February 2019, 10:36 AM
P568: Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn’s disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Dussias, N.(1);Rizzello, F.(1);Calabrese, C.(1);Sanna Passino, A.(1);Melotti, L.(1);Scaioli, E.(1);Belluzzi, A.(1);Gionchetti, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P568: Impact of Biologics and Small Molecules for Inflammatory Bowel Disease on COVID-19 Related Hospitalization: A Systematic Review and Meta-analysis
Year: 2022
Source: ECCO'22
Authors: Alrashed, F.(1);Alasfour, H.(2);Shehab, M.(3);
Created: Friday, 11 February 2022, 3:56 PM
P568: Patients with ulcerative colitis after pouch surgery are at risk for low spinal bone mineral density: a cross sectional study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pfeffer-Gik, T.(1)*;Godny , L.(1);Ollech, J.(1);Wasserberg, N.(2);White , I.(2);Barkan , R.(1);Cohen , S.(1);Avni-Biron, I.(1);Banai, H.(1);Snir, Y.(1);Yanai, H.(1);Yackobovich Gavan, M.(3,4);Shimon , I.(5);Tsvetov, G.(5);Broitman, Y.(1);Dotan, I.(1);
Created: Friday, 14 July 2023, 11:05 AM
P568: The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. FitzPatrick*, T. Ambrose, L. Thomas, S. Cullen, G. Blackburn, K. Davies, S. Travis, S. Keshav, A. Walsh, R. Palmer, S. Cripps, O. Brain

Created: Thursday, 21 February 2019, 9:14 AM
P569 The role of multidrug-resistant infections in IBD patients undergoing surgery
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Colombo1, G.M.B. Lamperti1, S. Antinori2, M. Corbellino2, G. Maconi3, S. Ardizzone3, D. Foschi1, G. Sampietro1

Created: Thursday, 30 January 2020, 10:12 AM
P569: A national, retrospective, observational study on the use of 5-aminosalicylates (5-ASA) in Crohn’s disease (CD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Hart1, S. C. Ng2, S. Ghosh3, J. Watkins4,5, J. Fullarton6, K. Paridaens*7

Created: Friday, 22 February 2019, 9:41 AM
P569: Can thiopurines prevent crohn's disease endoscopic postoperative recurrence in at risk patients?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chehaider, A.(1)*;Serghini, M.(1);Labidy, A.(1);Ben Mustapha, N.(1);Fekih, M.(1);Boubaker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P569: Fecal Microbiome Transplantation for Recurrent C. difficile Colitis: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series
Year: 2022
Source: ECCO'22
Authors: Urbonas, T.(1,2);Ianiro, G.(3,4);Gedgaudas, R.(1,2);Sabanas, P.(1,2);Urba, M.(1,2);Kiudelis, V.(1,2);Kiudelis, G.(1,2);Petkevicius, V.(1,2);Vitkauskiene, A.(5);Cammarota, G.(3,4);Gasbarrini, A.(3,4);Kupcinskas, J.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P569: Online education significantly improved gastroenterologists' knowledge of management strategies and treatment options for ulcerative colitis.
Year: 2021
Source: ECCO'21 Virtual
Authors: Bell, E.(1);Calle, M.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P569: Outcomes of IBD patients treated with infliximab: The impact of therapeutic drug monitoring in real-life clinical practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Kamperidis, P. Middleton, T. Tyrrell, I. Stasinos, N. Arebi

Created: Thursday, 21 February 2019, 9:14 AM
P569: Sequential rescue treatments in steroid refractory ulcerative colitis: two-year follow-up
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Protic M.*1, Seibold F.2,3, Manser C.4, Frei P.5, Mottet C.6, Juillerat P.7, Knezevic T.1, Rogler G.4, Beglinger C.8, Schoepfer A.9, Vavricka S.10

Created: Wednesday, 20 February 2019, 10:36 AM
P570 The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Singh Singh1, A. Al-Khoury1, Z. Kurti2, L. Gonczi3, P. Golovics3, R. Kohen1, W. Afif1, G. Wild1, E. Seidman1, A. Bitton1, T. Bessissow1, P. Lakatos2

Created: Thursday, 30 January 2020, 10:12 AM